Development of a Novel Method to Measure Insulin Sensitivity in Humans: A Pilot Study

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

February 21, 2022

Study Completion Date

February 21, 2022

Conditions
Insulin Sensitivity
Interventions
DEVICE

24h Continuous glucose monitoring and urinary C-peptide collection

Participants will be admitted to the research clinic for a 24-hour stay in a metabolic chamber. During the chamber stay, all urine excreted will be collected to assess C-peptide urinary excretion rate and interstitial glucose will be measured by a continuous glucose monitor (CGM). Participants will consume a eucaloric diet (50% carbohydrates, 30% fat and 20% protein).

Trial Locations (1)

70809

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
lead

Pennington Biomedical Research Center

OTHER

NCT04774081 - Development of a Novel Method to Measure Insulin Sensitivity in Humans: A Pilot Study | Biotech Hunter | Biotech Hunter